Location History:
- Arlington, MA (US) (1989 - 1995)
- Indianapolis, IN (US) (1993 - 2000)
Company Filing History:
9 out of 389 
2 out of 525 
1 out of 3 Years Active: 1989-2000
Title: Innovations of Yu-Chung Yang in Hematopoietic Therapy
Introduction
Yu-Chung Yang, an innovative inventor based in Indianapolis, IN, has made significant contributions to the field of biomedical research through his 12 patents. His groundbreaking work focuses on the use of interleukin-11 (IL-11), a novel mammalian cytokine, in medical treatments that enhance the immune response and aid the hematopoietic system.
Latest Patents
Among Yu-Chung Yang's latest patents are methods and compositions for utilizing IL-11 in pharmaceutical preparations. These patents outline processes for producing this cytokine, which has substantial implications for treating deficiencies in hematopoietic activity. The involvement of IL-11 in stimulating and enhancing crucial immune cells positions it as a potential game-changer in therapeutic applications.
Career Highlights
Throughout his career, Yang has worked with esteemed organizations such as Genetics Institute, Inc. and the Ludwig Institute for Cancer Research Limited. His experiences in these institutions have allowed him to further develop his expertise and focus on innovative approaches to enhance health outcomes through cytokine research.
Collaborations
Yang has collaborated with esteemed professionals in the field, including Steven C Clark and Agnes B Ciarletta. These partnerships have fostered a dynamic research environment, contributing to the advancement of treatments focused on immune response and hematopoietic system functionality.
Conclusion
Yu-Chung Yang's portfolio showcases his dedication to innovation in the biomedical sector. With his recent work on IL-11 and a history of collaboration with leading researchers, Yang continues to push the boundaries of science and develop solutions that hold great promise for patients in need of enhanced immune therapies.